Navigation Links
A 'bionic nose' that knows
Date:3/30/2009

Both cancer cells and the chemicals used to make bombs can foil detection because they appear in trace amounts too small for conventional detection techniques. Tel Aviv University has developed the ultimate solution: a molecule that can magnify weak traces of "hidden" molecules into something we can detect and see.

Using molecular techniques in nanotechnology, Prof. Doron Shabat of TAU's Raymond and Beverly Sackler School of Chemistry has engineered new molecules that have the power to identify targets -- such as biomarkers in cancer, materials in explosives, or pollutants in water --even when present in miniscule amounts. Prof. Shabat's invention, like a bionic nose, can "sniff out" these trace molecules and amplify them tenfold, making them noticeable for doctors and crimefighters.

Details of Prof. Shabat's project appeared in a paper published in the journal Chemical Communication last year.

Fights Chemical and Biological Threats In Our Bodies and Environment

Prof. Shabat, a bioorganic chemist, plans to develop the technology so that it amplifies signals millions and billions times stronger than they are. "We are developing a molecular system that amplifies certain events," says Prof. Shabat. "That way we'll be able to respond faster to medical, security and environmental threats. In effect, our device can amplify just about any chemical system that has a certain kind of reactivity."

"It has the potential to help doctors diagnose diseases -- those with biomarkers, and enzymatic activities that are compatible with our molecular probe," says Prof. Shabat. "The long list includes a few kinds of cancer, as well, including prostate cancer. But it also has applications for testing for impurities in water. It has both biological and non-biological applications."

A Track-and-Trace Solution

Prof. Shabat's invention is a molecular sensor that acts in a solution. A chemist would add trace amounts of the test material from the field -- a spoonful of contaminated drinking water, for example -- into the solution and would simply see if the color of the solution changes. If so, the targeted material -- the cancer, or explosive, or pollutant -- is present.

As of now, Prof. Shabat's is a unique solution. The prototype is ready, and Prof. Shabat plans to use it to "amplify" problems around the world to improve healthcare, safety, and security. Some of the research behind the new invention was done in collaboration with the Scripps Research Institute in San Diego.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. Bioniche Reports Fiscal 2008 Second Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... At Creekwood Dental Arts, Drs. Donna G. Miller and Michelle Hinds are ... in Waco, TX, using the latest dental technology for digital imagery and bite ... details in the oral cavity for accurate diagnoses and customized care plans. These tools ...
(Date:7/20/2017)... ... July 19, 2017 , ... A July 7th ... to, or worsen, varicose veins in some patients, according to medical experts. Washington ... not-so-good practices, like excessive sitting or standing, or regularly nicking yourself while shaving ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... , What Strategic Decisions Do You Need to Consider?, **An FDAnews Webinar**, Aug. ... , 42 CFR Part 11, “Final Rule for Clinical Trials Registration and Results ...
(Date:7/18/2017)... ... July 18, 2017 , ... Heritage Woods of Benton, a Gardant ... 12:30 p.m. on Aug. 15. , The community, which is located at 1305 Bailey ... who need some help to maintain their independence. , The lunch menu will include ...
(Date:7/17/2017)... ... July 17, 2017 , ... McGraw Family Pledges $3 Million for New Learning ... of Healthcare Clinicians , NORWALK, Connecticut – July 17, 2017 – The McGraw ... in community health by pledging up to $3 million in a challenge gift to ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017 In vitro diagnostics ... start of May, at least ten diagnostic companies have ... investments, public offerings and a loan facility.  The size ... almost $80 million.  Kalorama Information provides a monthly ... Diagnostics Knowledge Center. ...
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
(Date:6/27/2017)... 2017   NuEyes (NuEyes Technologies Inc.) today announced ... its growth in helping the legally blind live more independent ... the leading developer of augmented, virtual and mixed reality smartglasses ... The undisclosed funding amount was provided by strategic partners as ... offices in Abu Dhabi , ...
Breaking Medicine Technology: